Vesicle Translocation and the Metabolic Syndrome
囊泡易位和代谢综合征
基本信息
- 批准号:10161017
- 负责人:
- 金额:$ 16.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAddressAdipocytesAffectAttenuatedBindingBiochemicalBiologyBody CompositionBody WeightC-terminalCell NucleusCell RespirationCell membraneCell surfaceCellsComplexDataDevelopmentDiabetes MellitusDiseaseElectron MicroscopyEndocytosisEndosomesEnergy MetabolismExocytosisFatty acid glycerol estersGLUT4 geneGene ExpressionGenetic Predisposition to DiseaseGlucoseGlucose TransporterGlycogenGoalsGolgi ApparatusHealthHormonesHumanHypertensionImageImpairmentIndividualInsulinInsulin ResistanceIntracellular MembranesKnockout MiceLeadLearningLinkLipidsLocationMediatingMembraneMetabolicMetabolic DiseasesMetabolic syndromeMethodsMicroscopyModelingMolecularMovementMuscleMuscle CellsMutagenesisMutationNon-Insulin-Dependent Diabetes MellitusObesityOvernutritionPathogenesisPathway interactionsPeptide HydrolasesPeptidesPhysiologicalPhysiologyPlasmaPreventionProcessProteinsProteolysisProteolytic ProcessingRegulationSiteSpecific qualifier valueSubcellular structureTestingTissuesTriglyceridesVasopressinsVesicleWorkblood glucose regulationglucose metabolismglucose uptakeimprovedin vivoknockout animalnovel strategiespreventsortilinsyntaxinsyntaxin 6syntaxin Asyntaxin binding protein 1trafficking
项目摘要
The regulation of glucose homeostasis is a complex process, which is disrupted in disease states such as type 2 diabetes. Insulin is the primary hormone that regulates glucose homeostasis. Insulin stimulates glucose uptake in muscle and fat by causing the movement of intracellular membranes containing GLUT4 glucose transporters, which fuse and insert GLUT4 at the cell surface. This effect of insulin is impaired in the setting of overnutrition, inactivity, and genetic predisposition, resulting in insulin resistance and contributing to the development of diabetes. Therefore, to understand the pathogenesis of metabolic disease, it is necessary to understand the molecular mechanisms that specify the trafficking of GLUT4 among intracellular membranes, and by which this trafficking is modulated by insulin and disrupted in insulin resistance. Previous work by this project identified the TUG protein as a major regulator of GLUT4 trafficking and glucose uptake in muscle and fat cells. The data support a model in which TUG mediates the intracellular retention of GLUT4, together with selected other proteins, in specific membrane vesicles within unstimulated cells. Insulin then mobilizes these vesicles by triggering TUG endoproteolytic cleavage. Cleavage coordinates glucose uptake with other physiologic effects, resulting from the action of proteins that are co-regulated with GLUT4 by this mechanism, as well as with possible effects on energy expenditure. In insulin resistant individuals, alterations in this membrane trafficking mechanism may contribute to multiple aspects of the metabolic syndrome. Yet, it remains unknown where TUG and GLUT4 are localized in cells, how this localization is affected in insulin resistance, and whether attenuated TUG cleavage can cause insulin resistance in vivo. To address these questions, three Aims will be undertaken. Aim 1 will characterize how TUG is able to trap the GLUT4-containing vesicles in unstimulated cells, and how it maintains these vesicles in an insulin-responsive configuration. Aim 2 will study the location and mechanism by which TUG anchors these vesicles to intracellular structures, and how this may be affected in insulin resistance. . Aim 3 will study the importance of TUG proteolysis in muscle for overall insulin action and glucose homeostasis. We anticipate that, together, these studies will result in an improved understanding of molecular mechanisms regulating glucose metabolism and energy expenditure, with implications for the prediction, prevention, and treatment of diabetes and the metabolic syndrome.
葡萄糖稳态的调节是一个复杂的过程,在2型糖尿病等疾病状态下被破坏。胰岛素是调节葡萄糖稳态的主要激素。胰岛素通过引起含有GLUT4葡萄糖转运体的细胞膜的运动来刺激肌肉和脂肪的葡萄糖摄取,这些转运体融合并将GLUT4插入细胞表面。胰岛素的这种作用在营养过剩、缺乏运动和遗传易感性的情况下受到损害,导致胰岛素抵抗并促进糖尿病的发展。因此,为了了解代谢性疾病的发病机制,有必要了解GLUT4在细胞膜内运输的分子机制,以及这种运输是如何被胰岛素调节并在胰岛素抵抗中中断的。该项目之前的工作确定了TUG蛋白是肌肉和脂肪细胞中GLUT4运输和葡萄糖摄取的主要调节因子。这些数据支持了一种模型,即在未受刺激的细胞中,TUG介导了GLUT4的细胞内保留,以及选定的其他蛋白质在特定的膜泡中。然后胰岛素通过触发TUG内源性蛋白水解裂解来动员这些囊泡。裂解协调了葡萄糖摄取和其他生理效应,这些生理效应是由与GLUT4共同调节的蛋白质的作用引起的,并可能对能量消耗产生影响。在胰岛素抵抗个体中,这种膜运输机制的改变可能导致代谢综合征的多个方面。然而,目前尚不清楚TUG和GLUT4在细胞中的定位,这种定位在胰岛素抵抗中如何受到影响,以及减弱的TUG切割是否会导致体内胰岛素抵抗。为了解决这些问题,将采取三个目标。目的1将描述TUG如何能够在未受刺激的细胞中捕获含有glut4的囊泡,以及它如何将这些囊泡维持在胰岛素反应状态。目的2将研究TUG将这些囊泡锚定到细胞内结构的位置和机制,以及这在胰岛素抵抗中可能受到的影响。目的3将研究肌肉中TUG蛋白水解对整体胰岛素作用和葡萄糖稳态的重要性。我们预计,这些研究将有助于提高对调节葡萄糖代谢和能量消耗的分子机制的理解,对糖尿病和代谢综合征的预测、预防和治疗具有重要意义。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A PPARγ-Bnip3 Axis Couples Adipose Mitochondrial Fusion-Fission Balance to Systemic Insulin Sensitivity.
- DOI:10.2337/db16-0243
- 发表时间:2016-09
- 期刊:
- 影响因子:7.7
- 作者:Tol MJ;Ottenhoff R;van Eijk M;Zelcer N;Aten J;Houten SM;Geerts D;van Roomen C;Bierlaagh MC;Scheij S;Hoeksema MA;Aerts JM;Bogan JS;Dorn GW 2nd;Argmann CA;Verhoeven AJ
- 通讯作者:Verhoeven AJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN BOGAN其他文献
JONATHAN BOGAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN BOGAN', 18)}}的其他基金
Regulation of insulin sensitivity by TUG acetylation
通过 TUG 乙酰化调节胰岛素敏感性
- 批准号:
8386145 - 财政年份:2012
- 资助金额:
$ 16.75万 - 项目类别:
Regulation of insulin sensitivity by TUG acetylation
通过 TUG 乙酰化调节胰岛素敏感性
- 批准号:
8516944 - 财政年份:2012
- 资助金额:
$ 16.75万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16.75万 - 项目类别:
Research Grant